Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1985 Jan;82(1):245–247. doi: 10.1073/pnas.82.1.245

Vasoactive intestinal peptide-containing neurons in the paraventricular nucleus may participate in regulating prolactin secretion.

E Mezey, J Z Kiss
PMCID: PMC397009  PMID: 3881755

Abstract

Vasoactive intestinal polypeptide (VIP) immunoreactivity is present in varicosities and fibers in the hypothalamic paraventricular nucleus (PVN) in normal control animals. Adrenalectomy and lactation combined with colchicine treatment results in the appearance of a large population of VIP-immunopositive cell bodies in the parvocellular part of the PVN. Adrenalectomy, as well as lactation, significantly increases the number of VIP-positive fibers in the external zone of the median eminence. These observations suggest that the VIP-immunopositive neurons in the PVN may participate in regulating prolactin and corticotropin secretion.

Full text

PDF
245

Images in this article

246Image
on p.246
246Image
on p.246
246Image
on p.246
246Image
on p.246

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antoni F. A., Palkovits M., Makara G. B., Linton E. A., Lowry P. J., Kiss J. Z. Immunoreactive corticotropin-releasing hormone in the hypothalamoinfundibular tract. Neuroendocrinology. 1983 Jun;36(6):415–423. doi: 10.1159/000123492. [DOI] [PubMed] [Google Scholar]
  2. Axelrod J., Reisine T. D. Stress hormones: their interaction and regulation. Science. 1984 May 4;224(4648):452–459. doi: 10.1126/science.6143403. [DOI] [PubMed] [Google Scholar]
  3. Besson J., Rotsztejn W., Laburthe M., Epelbaum J., Beaudet A., Kordon C., Rosselin G. Vasoactive intestinal peptide (VIP): brain distribution, subcellular localization and effect of deafferentation of the hypothalamus in male rats. Brain Res. 1979 Apr 6;165(1):79–85. doi: 10.1016/0006-8993(79)90046-5. [DOI] [PubMed] [Google Scholar]
  4. Giachetti A., Said S. I., Reynolds R. C., Koniges F. C. Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3424–3428. doi: 10.1073/pnas.74.8.3424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gillies G. E., Linton E. A., Lowry P. J. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature. 1982 Sep 23;299(5881):355–357. doi: 10.1038/299355a0. [DOI] [PubMed] [Google Scholar]
  6. Harms P. G., Langlier P., McCann S. M. Modification of stress-induced prolactin release by dexamethasone or adrenalectomy. Endocrinology. 1975 Feb;96(2):475–478. doi: 10.1210/endo-96-2-475. [DOI] [PubMed] [Google Scholar]
  7. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  8. Hsu S. M., Ree H. J. Self-sandwich method. An improved immunoperoxidase technic for the detection of small amounts of antigens. Am J Clin Pathol. 1980 Jul;74(1):32–40. doi: 10.1093/ajcp/74.1.32. [DOI] [PubMed] [Google Scholar]
  9. Hökfelt T., Fahrenkrug J., Tatemoto K., Mutt V., Werner S., Hulting A. L., Terenius L., Chang K. J. The PHI (PHI-27)/corticotropin-releasing factor/enkephalin immunoreactive hypothalamic neuron: possible morphological basis for integrated control of prolactin, corticotropin, and growth hormone secretion. Proc Natl Acad Sci U S A. 1983 Feb;80(3):895–898. doi: 10.1073/pnas.80.3.895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kato Y., Iwasaki Y., Iwasaki J., Abe H., Yanaihara N., Imura H. Prolactin release by vasoactive intestinal polypeptide in rats. Endocrinology. 1978 Aug;103(2):554–558. doi: 10.1210/endo-103-2-554. [DOI] [PubMed] [Google Scholar]
  11. Kiss J. Z., Mezey E., Skirboll L. Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1854–1858. doi: 10.1073/pnas.81.6.1854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lechan R. M., Nestler J. L., Jacobson S., Reichlin S. The hypothalamic 'tuberoinfundibular' system of the rat as demonstrated by horseradish peroxidase (HRP) microiontophoresis. Brain Res. 1980 Aug 11;195(1):13–27. doi: 10.1016/0006-8993(80)90862-8. [DOI] [PubMed] [Google Scholar]
  13. Rotsztejn W. H., Benoist L., Besson J., Beraud G., Bluet-Pajot M. T., Kordon C., Rosselin G., Duval J. Effect of vasoactive intestinal peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Inhibition by dexamethasone of vip-induced prolactin release. Neuroendocrinology. 1980 Oct;31(4):282–286. doi: 10.1159/000123089. [DOI] [PubMed] [Google Scholar]
  14. Said S. I., Mutt V. Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur J Biochem. 1972 Jul 13;28(2):199–204. doi: 10.1111/j.1432-1033.1972.tb01903.x. [DOI] [PubMed] [Google Scholar]
  15. Said S. I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science. 1970 Sep 18;169(3951):1217–1218. doi: 10.1126/science.169.3951.1217. [DOI] [PubMed] [Google Scholar]
  16. Said S. I., Porter J. C. Vasoactive intestinal polypeptide: release into hypophyseal portal blood. Life Sci. 1979 Jan 15;24(3):227–230. doi: 10.1016/0024-3205(79)90223-6. [DOI] [PubMed] [Google Scholar]
  17. Sawchenko P. E., Swanson L. W., Vale W. W. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1883–1887. doi: 10.1073/pnas.81.6.1883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Swanson L. W., Sawchenko P. E., Wiegand S. J., Price J. L. Separate neurons in the paraventricular nucleus project to the median eminence and to the medulla or spinal cord. Brain Res. 1980 Sep 29;198(1):190–195. doi: 10.1016/0006-8993(80)90354-6. [DOI] [PubMed] [Google Scholar]
  19. Tatemoto K., Mutt V. Isolation and characterization of the intestinal peptide porcine PHI (PHI-27), a new member of the glucagon--secretin family. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6603–6607. doi: 10.1073/pnas.78.11.6603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tramu G., Croix C., Pillez A. Ability of the CRF immunoreactive neurons of the paraventricular nucleus to produce a vasopressin-like material. Immunohistochemical demonstration in adrenalectomized guinea pigs and rats. Neuroendocrinology. 1983 Dec;37(6):467–469. doi: 10.1159/000123595. [DOI] [PubMed] [Google Scholar]
  21. Vijayan E., Samson W. K., Said S. I., McCann S. M. Vasoactive intestinal peptide: evidence for a hypothalamic site of action to release growth hormone, luteinizing hormone, and prolactin in conscious ovariectomized rats. Endocrinology. 1979 Jan;104(1):53–57. doi: 10.1210/endo-104-1-53. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES